Replies to post #6245 on Synaptogenix Inc (SNPX)

[Cyosol]

I made a prediction a while back saying that they'll issue 2 million more shares for $10 each, bringing in $20 million in total.

A positive confirmatory trial could then send the share price soaring and inspire investors to exercise their warrants and inject some more cash into the company.

Neurotrope could potentially then have about $90 million in the bank for the upcoming phase 3.